Earl Martin Douglas - 14 Aug 2023 Form 3 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Signature
/s/Lillian Smith, Attorney-in-Fact
Issuer symbol
ALLO
Transactions as of
14 Aug 2023
Net transactions value
$0
Form type
3
Filing time
17 Aug 2023, 14:50:26 UTC
Next filing
31 Jan 2024

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.